T.Man Pharmaceutical PCL (BKK:TMAN)

T.Man Pharmaceutical PCL Revenue

T.Man Pharmaceutical PCL had revenue of 633.71M THB in the quarter ending March 31, 2026, with 5.80% growth. This brings the company's revenue in the last twelve months to 2.56B, up 14.53% year-over-year. In the year 2025, T.Man Pharmaceutical PCL had annual revenue of 2.53B with 13.48% growth.

• Revenue (ttm): 2.56B
• Revenue Growth: +14.53%
• P/S Ratio: 1.69
• Revenue / Employee: 2.71M
• Employees: 944
• Market Cap: 4.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.53B	300.06M	13.48%
Dec 31, 2024	2.23B	245.96M	12.42%
Dec 31, 2023	1.98B	-44.61M	-2.20%
Dec 31, 2022	2.02B	761.31M	60.26%
Dec 31, 2021	1.26B	362.56M	40.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error